Twist Bioscience to help test for SARS-CoV-2 variant

Country

United States

Twist Bioscience Corp has announced plans to offer a new control that could be used to alter protocols for tests currently in use to diagnose SARS-CoV-2 in order to detect a variant strain of the virus in circulation in the UK and other countries. In a statement issued on 23 December, the company said the new synthetic RNA control should be available by 15 January 2021.